MELBOURNE, Australia--(BUSINESS WIRE)--Australian healthtech Everlab has raised AU$65m in Series A funding. The oversubscribed round was led by Airtree Ventures (AU), with participation from global ...
Australia-based Everlab, a company offering an AI platform designed to support preventative care, announced it has secured US$10 million (AU$15 million) in seed funding in a round led by Left Lane ...
L-R: Everlab founding team. Marc Hermann (CEO), Anshul Jain (Chief Tech and Product Officer), Dr Steven Lu (Chief Medical Officer), Sam Kothari (COO). Image: Supplied Melbourne healthtech startup ...
The healthcare start-up plans to expand aggressively and take its AI-powered longevity screening global, starting with the UK.
The Melbourne healthtech’s oversubscribed Series A, led by Airtree, funds a move into the UK and a pitch to coordinate a patient’s health data over a lifetime rather than a single appointment. Most ...
L-R: Everlab founding team. Marc Hermann (CEO), Anshul Jain (Chief Tech and Product Officer), Dr Steven Lu (Chief Medical Officer), Sam Kothari (COO). Image: Supplied Melbourne healthtech startup ...
Backed by a famous cricketer and valued at almost $500 million, Everlab wants to make preventative health mainstream. The science is still catching up.
Mr Hermann, founder and chief executive of Melbourne-based Everlab, charges $3000 for a “flagship” assessment of one’s health, providing a “50-year personalised health road map”. He has fused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results